Neonatal exposure to sevoflurane induces adolescent neurobehavioral dysfunction by interfering with hippocampal glycerophoslipid metabolism in rats
Cerebral Cortex · 2023
DOI: 10.1093/cercor/bhac185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cerebral Cortex, 2023. Verfasst von Yonghai Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation Yantai University, Ministry of Education, Collaborative Innovation C…. Hauptthemen laut MEDLINE: Anesthetics, Inhalation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Sevoflurane exposure in the neonatal period causes long-term developmental neuropsychological dysfunction, including memory impairment and anxiety-like behaviors. However, the molecular mechanisms underlying such effects have not been fully elucidated. In this study, we investigated the effect of neonatal exposure to sevoflurane on neurobehavioral profiles in adolescent rats, and applied an integrated approach of lipidomics and proteomics to investigate the molecular network implicated in neurobehavioral dysfunction. We found that neonatal exposure to sevoflurane caused cognitive impairment and social behavior deficits in adolescent rats. Lipidomics analyses revealed that sevoflurane significantly remodeled hippocampal lipid metabolism, including lysophatidylcholine (LPC) metabolism, phospholipid carbon chain length and carbon chain saturation. Through a combined proteomics analysis, we found that neonatal exposure to sevoflurane significantly downregulated the expression of lysophosphatidylcholine acyltransferase 1 (LPCAT1), a key enzyme in the regulation of phospholipid metabolism, in the hippocampus of adolescent rats. Importantly, hippocampal LPCAT1 overexpression restored the dysregulated glycerophospholipid (GP) metabolism and alleviated the learning and memory deficits caused by sevoflurane. Collectively, our evidence that neonatal exposure to sevoflurane downregulates LPCAT1 expression and dysregulates GP metabolism in the hippocampus, which may contribute to the neurobehavioral dysfunction in the adolescent rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation Yantai University, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universiti…
- National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, #1 Keyuan Road 4, Gaopeng Street, High-…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Li, H., Zhao, Y., Qin, F., Wang, L., Jiang, L., Wang, X., Chen, R., He, Y., Wei, Q., Li, S., Chen, Y., Xiao, Y., Dai, Y., Bu, Q., Zhao, Y., Tian, J., Wang, H., & Cen, X. (2023). Neonatal exposure to sevoflurane induces adolescent neurobehavioral dysfunction by interfering with hippocampal glycerophoslipid metabolism in rats. Cerebral Cortex. https://doi.org/10.1093/cercor/bhac185
Vancouver
Wang Y, Li H, Zhao Y, Qin F, Wang L, Jiang L, et al. Neonatal exposure to sevoflurane induces adolescent neurobehavioral dysfunction by interfering with hippocampal glycerophoslipid metabolism in rats. Cerebral Cortex. 2023. doi:10.1093/cercor/bhac185
BibTeX
@article{Wang2023,
author = {Wang, Yonghai and Li, Hongchun and Zhao, Ying and Qin, Feng and Wang, Liang and Jiang, Linhong and Wang, Xiaojie and Chen, Rong and He, Yuman and Wei, Qinfan and Li, Shu and Chen, Yuanyuan and Xiao, Yuzhou and Dai, Yanping and Bu, Qian and Zhao, Yinglan and Tian, Jingwei and Wang, Hongbo and Cen, Xiaobo},
title = {Neonatal exposure to sevoflurane induces adolescent neurobehavioral dysfunction by interfering with hippocampal glycerophoslipid metabolism in rats},
journal = {Cerebral Cortex},
year = {2023},
doi = {10.1093/cercor/bhac185}
}
EUVIMED